You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 31, 2025

OXYCODONE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Oxycodone, and when can generic versions of Oxycodone launch?

Oxycodone is a drug marketed by Bristol Myers Squibb, Actavis Elizabeth, Barr, Duramed Pharms Barr, Halsey, Mallinckrodt, Mutual Pharm, Vintage Pharms, Vintage Pharms Llc, Watson Labs, Abhai Llc, Mikart, Sankalp Lifecare, Specgx Llc, Alvogen, Amneal Pharms, Amneal Pharms Ny, Ascent Pharms Inc, Aurolife Pharma Llc, Chartwell, Dr Reddys Labs Sa, Elite Labs Inc, Epic Pharma Llc, Granules, Lannett Co Inc, Nesher Pharms, Novel Labs Inc, Ph Health, Rhodes Pharms, Sanaluz, Sun Pharm Inds Inc, Wes Pharma Inc, Actavis Labs Fl Inc, Ani Pharms, Sun Pharm Industries, Roxane, Avanthi Inc, Genus Lifesciences, Alkem Labs Ltd, Chartwell Molecular, Hibrow Hlthcare, Hikma, Pharm Assoc, Pharmobedient, Quagen, Vistapharm Llc, Nuvo Pharm, Strides Pharma Intl, and Barr Labs Inc. and is included in one hundred and eleven NDAs.

The generic ingredient in OXYCODONE is ibuprofen; oxycodone hydrochloride. There are sixty-four drug master file entries for this compound. Additional details are available on the ibuprofen; oxycodone hydrochloride profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for OXYCODONE?
What are the global sales for OXYCODONE?
What is Average Wholesale Price for OXYCODONE?

Summary for OXYCODONE

US Patents:	0
Applicants:	49
NDAs:	111
Drug Prices:	Drug price information for OXYCODONE
Drug Sales Revenues:	Drug sales revenues for OXYCODONE
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for OXYCODONE
DailyMed Link:	OXYCODONE at DailyMed

Drug patent expirations by year for OXYCODONE

Drug Prices for OXYCODONE

Recent Clinical Trials for OXYCODONE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Baylor College of Medicine	PHASE1
Christopher D. Verrico	PHASE1
University of South Alabama	PHASE4

See all OXYCODONE clinical trials

Medical Subject Heading (MeSH) Categories for OXYCODONE

Analgesics, Opioid
Narcotics

Anatomical Therapeutic Chemical (ATC) Classes for OXYCODONE

N02AA	Natural opium alkaloids
N02A	OPIOIDS
N02	ANALGESICS
N	Nervous system

Paragraph IV (Patent) Challenges for OXYCODONE

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
XTAMPZA ER	Extended-release Capsules	oxycodone	9 mg, 13.5 mg, 18 mg, 27 mg and 36 mg	208090	1	2017-11-15

US Patents and Regulatory Information for OXYCODONE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mikart	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	040679-001	May 16, 2006		DISCN	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Watson Labs	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	040535-002	Sep 5, 2003		DISCN	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Aurolife Pharma Llc	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	201972-003	Jul 15, 2013	AA	RX	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Amneal Pharms Ny	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	040778-001	Nov 27, 2007	AA	RX	No	No	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
Avanthi Inc	OXYCODONE HYDROCHLORIDE	oxycodone hydrochloride	TABLET;ORAL	091393-002	Aug 31, 2009	AB	RX	No	Yes	⤷ Get Started Free	⤷ Get Started Free				⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.